India has evolved significantly in the clinical trial setting...we have a significant number of patients and trials running in IndiaAshraf Al-Ouf Head, Pharmaceutical Commercial Ops, APAC, Bayer
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/HNKCDW5
via IFTTT
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
So I’m currently on a lean bulk on 2900 a day. And I wake up 6 am I have oats and protein powder or fruit then go gym around 9 am Then at ...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(640)
-
▼
October
(17)
- Nanavati Max Hospital inks pact with Namangan Vilo...
- Eli Lilly to invest over $1 billion in India to ex...
- Cough syrup issue: Health ministry directs rationa...
- NSE to build Rs 380-crore facility for cancer trea...
- India's TB fight gets a boost: New Made-in-India d...
- Torrent Pharma gets demand notices totalling Rs 6....
- Health Ministry confirms Diethylene Glycol beyond ...
- Tamil Nadu bans ''Coldrif'' cough syrup after chil...
- Isabgol processors threaten to halt purchases from...
- Indian Pharmaceutical Alliance appoints Zydus Life...
- IPA names Zydus Lifesciences MD Sharvil Patel as P...
- Panacea Biotec gets supply order from UNICEF for o...
- Government invites proposals under PRIP scheme for...
- Novo, Lilly weight-loss drugs should be first opti...
- Pricing depends on the country, Bayer looks at aff...
- 'Contaminated' cough syrup linked deaths: NCDS col...
- Indian pharma Wockhardt seeks US approval for new ...
-
▼
October
(17)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment